Lutetium-(177Lu)-oxodotreotide: Lack of efficacy.
In: Reactions Weekly, Jg. 1984 (2023-11-25), Heft 1, S. 314-314
serialPeriodical
Zugriff:
In a single-centre prospective study, a patient with metastatic pheochromocytoma/paraganglioma (PPGL) exhibited lack of efficacy during treatment with lutetium-(177Lu)-oxodotreotide. The patient had previously undergone complete PPGL surgery and was initiated on a treatment with lutetium-(177Lu)-oxodotreotide. However, the patient experienced disease progression, as indicated by a significant increase in chromogranin A concentration, suggesting treatment-refractory PPGL. [Extracted from the article]
Titel: |
Lutetium-(177Lu)-oxodotreotide: Lack of efficacy.
|
---|---|
Zeitschrift: | Reactions Weekly, Jg. 1984 (2023-11-25), Heft 1, S. 314-314 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0114-9954 (print) |
DOI: | 10.1007/s40278-023-50545-4 |
Schlagwort: |
|
Sonstiges: |
|